These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9512123)
21. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996 [TBL] [Abstract][Full Text] [Related]
22. Sulindac therapy of colorectal polyps in familial adenomatous polyposis. Tonelli F; Valanzano R; Dolara P Dig Dis; 1994; 12(5):259-64. PubMed ID: 7882547 [TBL] [Abstract][Full Text] [Related]
23. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM Carcinogenesis; 1998 Jan; 19(1):87-91. PubMed ID: 9472698 [TBL] [Abstract][Full Text] [Related]
24. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090 [TBL] [Abstract][Full Text] [Related]
25. [Role of suindac in the treatment of familial adenomatous polyposis coli]. Landauer S; Halimi C; Caulin C; Bergmann JF Therapie; 1999; 54(6):675-82. PubMed ID: 10709439 [TBL] [Abstract][Full Text] [Related]
26. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients]. Li J; Lv YM; Jin Z; Cui RL Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):371-3. PubMed ID: 16086054 [TBL] [Abstract][Full Text] [Related]
27. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902 [TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688 [TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? Tonelli F; Valanzano R; Messerini L; Ficari F J Surg Oncol; 2000 May; 74(1):15-20. PubMed ID: 10861602 [TBL] [Abstract][Full Text] [Related]
30. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors. Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091 [TBL] [Abstract][Full Text] [Related]
31. [Treatment with sulindac of adenomatous polyps in familial polyposis]. Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106 [TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis. Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918 [TBL] [Abstract][Full Text] [Related]
33. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Pasricha PJ; Bedi A; O'Connor K; Rashid A; Akhtar AJ; Zahurak ML; Piantadosi S; Hamilton SR; Giardiello FM Gastroenterology; 1995 Sep; 109(3):994-8. PubMed ID: 7657130 [TBL] [Abstract][Full Text] [Related]
34. [Chemoprevention of familial cancer]. Ishikawa H Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803 [TBL] [Abstract][Full Text] [Related]
35. Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis. Friederich P; Verschuur J; van Heumen BW; Roelofs HM; Berkhout M; Nagtegaal ID; van Oijen MG; van Krieken JH; Peters WH; Nagengast FM Int J Colorectal Dis; 2011 May; 26(5):575-82. PubMed ID: 21243500 [TBL] [Abstract][Full Text] [Related]
36. Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Guldenschuh I; Hurlimann R; Muller A; Ammann R; Mullhaupt B; Dobbie Z; Zala GF; Flury R; Seelentag W; Roth J; Meyenberger C; Fried M; Hoppeler T; Spigelman AD; Scott RJ Dis Colon Rectum; 2001 Aug; 44(8):1090-7; discussion 1097-9. PubMed ID: 11535846 [TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943 [TBL] [Abstract][Full Text] [Related]
38. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma. Thompson PA; Wertheim BC; Zell JA; Chen WP; McLaren CE; LaFleur BJ; Meyskens FL; Gerner EW Gastroenterology; 2010 Sep; 139(3):797-805, 805.e1. PubMed ID: 20538001 [TBL] [Abstract][Full Text] [Related]
39. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis. Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578 [TBL] [Abstract][Full Text] [Related]
40. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Heiskanen I; Järvinen HJ Int J Colorectal Dis; 1997; 12(1):9-13. PubMed ID: 9112143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]